Symbols / OMCL Stock $43.12 -1.55% Omnicell, Inc.

Healthcare • Health Information Services • United States • NMS
OMCL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Randall A. Lipps
Exch · Country NMS · United States
Market Cap 1.96B
Enterprise Value 1.95B
Income 20.43M
Sales 1.23B
FCF (ttm) 112.56M
Book/sh 27.36
Cash/sh 5.26
Employees 3,525
Insider 10d —
IPO Aug 09, 2001
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 98.00
Forward P/E 19.64
PEG 15.40
P/S 1.60
P/B 1.58
P/C —
EV/EBITDA 26.56
EV/Sales 1.60
Quick Ratio 1.04
Current Ratio 1.50
Debt/Eq 16.09
LT Debt/Eq —
EPS (ttm) 0.44
EPS next Y 2.19
EPS Growth —
Revenue Growth 14.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-28
Earnings (prior) 2026-04-28
ROA 1.21%
ROE 1.63%
ROIC —
Gross Margin 43.87%
Oper. Margin 5.44%
Profit Margin 1.67%
Shs Outstand 45.48M
Shs Float 41.95M
Insider Own 2.20%
Instit Own 105.36%
Short Float 7.20%
Short Ratio 4.64
Short Interest 2.70M
52W High 55.00
vs 52W High -21.60%
52W Low 26.85
vs 52W Low 60.60%
Beta 0.96
Impl. Vol. 56.84%
Rel Volume 0.92
Avg Volume 596.82K
Volume 549.73K
Target (mean) $61.29
Tgt Median $60.00
Tgt Low $55.00
Tgt High $70.00
# Analysts 7
Recom Strong_buy
Prev Close $43.80
Price $43.12
Change -1.55%
About

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$61.29
Mean price target
2. Current target
$43.12
Latest analyst target
3. DCF / Fair value
$44.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$43.12
Low
$55.00
High
$70.00
Mean
$61.29

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-29 main Keybanc Overweight → Overweight $70
2026-04-23 main Wells Fargo Overweight → Overweight $55
2026-02-06 reit Piper Sandler Overweight → Overweight $49
2026-02-02 main Benchmark Buy → Buy $60
2026-01-08 up Keybanc Sector Weight → Overweight $60
2026-01-05 main Wells Fargo Overweight → Overweight $52
2025-12-09 main B of A Securities Neutral → Neutral $46
2025-12-09 main Benchmark Buy → Buy $50
2025-10-31 main Benchmark Buy → Buy $45
2025-08-11 main Piper Sandler Overweight → Overweight $55
2025-07-21 main Wells Fargo Overweight → Overweight $40
2025-07-14 main B of A Securities Neutral → Neutral $32
2025-05-23 main Wells Fargo Overweight → Overweight $37
2025-05-23 main B of A Securities Neutral → Neutral $34
2025-05-14 up Wells Fargo Equal-Weight → Overweight $35
2025-05-07 main Benchmark Buy → Buy $40
2025-05-07 main Wells Fargo Equal-Weight → Equal-Weight $31
2025-05-07 main B of A Securities Neutral → Neutral $30
2025-04-17 main Wells Fargo Equal-Weight → Equal-Weight $38
2025-03-20 main JP Morgan Neutral → Neutral $36
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 LIPPS RANDALL A Chief Executive Officer — 90,939 $0.00 $0
2026-04-01 MANLEY COREY J Officer — 25,132 $0.00 $0
2026-04-01 NJOKU NNAMDI Chief Operating Officer — 46,296 $0.00 $0
2026-04-01 RADFORD HARLAN BAIRD III Chief Financial Officer — 37,037 $0.00 $0
2026-04-01 NUTT BRIAN H Officer — 5,556 $0.00 $0
2026-03-16 MANLEY COREY J Officer — 7,405 $34.69 $256,879
2026-03-13 LIPPS RANDALL A Chief Executive Officer — 79,494 $0.00 $0
2026-03-13 MANLEY COREY J Officer — 22,445 $0.00 $0
2026-03-13 NJOKU NNAMDI Chief Operating Officer — 37,409 $0.00 $0
2026-02-17 MANLEY COREY J Officer — 4,243 $36.59 $155,251
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,184.85
+6.53%
1,112.24
-3.04%
1,147.11
-11.48%
1,295.95
Operating Revenue
1,184.85
+6.53%
1,112.24
-3.04%
1,147.11
-11.48%
1,295.95
Cost Of Revenue
681.40
+6.26%
641.24
-1.39%
650.27
-8.02%
706.96
Reconciled Cost Of Revenue
681.40
+6.26%
641.24
-1.39%
650.27
-8.02%
706.96
Gross Profit
503.44
+6.89%
471.00
-5.20%
496.84
-15.64%
588.99
Operating Expense
498.28
+5.87%
470.67
-11.48%
531.71
-10.08%
591.31
Research And Development
88.67
-1.92%
90.41
-6.90%
97.11
-7.48%
104.97
Selling General And Administration
409.61
+7.72%
380.25
-12.50%
434.59
-10.64%
486.34
Total Expenses
1,179.68
+6.10%
1,111.90
-5.93%
1,181.98
-8.96%
1,298.27
Operating Income
5.16
+1431.16%
0.34
+100.97%
-34.87
-1400.99%
-2.32
Total Operating Income As Reported
5.16
+1431.16%
0.34
+100.97%
-34.87
-1400.99%
-2.32
EBITDA
91.79
+1.89%
90.09
+48.45%
60.69
-37.33%
96.85
Normalized EBITDA
91.79
+1.89%
90.09
+48.45%
60.69
-37.33%
96.85
Reconciled Depreciation
86.63
-3.48%
89.75
-6.07%
95.56
-3.64%
99.17
EBIT
5.16
+1431.16%
0.34
+100.97%
-34.87
-1400.99%
-2.32
Net Income
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Pretax Income
11.32
-55.75%
25.59
+227.28%
-20.11
-719.73%
-2.45
Net Non Operating Interest Income Expense
6.17
-75.59%
25.26
+71.11%
14.76
+11453.85%
-0.13
Net Interest Income
6.17
-75.59%
25.26
+71.11%
14.76
+11453.85%
-0.13
Tax Provision
9.27
-29.01%
13.06
+4866.54%
0.26
+103.25%
-8.10
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Net Income From Continuing Operation Net Minority Interest
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Net Income From Continuing And Discontinued Operation
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Net Income Continuous Operations
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Normalized Income
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Net Income Common Stockholders
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Diluted EPS
0.04
-85.19%
0.27
+160.00%
-0.45
-475.00%
0.12
Basic EPS
0.04
-85.19%
0.27
+160.00%
-0.45
-446.15%
0.13
Basic Average Shares
45.97
-0.18%
46.05
+1.85%
45.21
+1.83%
44.40
Diluted Average Shares
46.36
+0.23%
46.26
+2.31%
45.21
-1.48%
45.89
Diluted NI Availto Com Stockholders
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Total Other Finance Cost
-6.17
+75.59%
-25.26
-71.11%
-14.76
-11453.85%
0.13
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,974.72
-6.89%
2,120.96
-4.76%
2,226.88
+0.73%
2,210.76
Current Assets
680.07
-16.61%
815.49
-12.08%
927.57
+5.19%
881.81
Cash Cash Equivalents And Short Term Investments
211.17
-44.67%
381.68
-20.46%
479.84
+40.37%
341.85
Cash And Cash Equivalents
196.52
-46.77%
369.20
-21.11%
467.97
+41.65%
330.36
Cash Equivalents
148.60
-54.70%
328.00
-27.27%
451.00
+49.83%
301.00
Cash Financial
47.92
+16.31%
41.20
+142.76%
16.97
-42.20%
29.36
Other Short Term Investments
14.65
+17.42%
12.47
+5.12%
11.87
+3.32%
11.49
Receivables
216.86
-15.42%
256.40
+1.74%
252.03
-15.84%
299.47
Accounts Receivable
216.86
-15.42%
256.40
+1.74%
252.03
-15.84%
299.47
Gross Accounts Receivable
225.73
-14.19%
263.04
+2.12%
257.59
-15.44%
304.62
Allowance For Doubtful Accounts Receivable
-8.87
-33.45%
-6.64
-19.43%
-5.56
-7.98%
-5.15
Inventory
100.91
+13.81%
88.66
-19.47%
110.10
-25.38%
147.55
Raw Materials
26.25
-21.66%
33.50
-34.87%
51.44
-32.19%
75.85
Work In Process
1.32
-12.81%
1.51
+14.17%
1.33
-85.70%
9.28
Finished Goods
73.34
+36.72%
53.64
-6.44%
57.33
-8.14%
62.41
Prepaid Assets
35.55
+30.32%
27.28
-20.35%
34.24
+19.02%
28.77
Current Deferred Assets
10.82
+24.30%
8.70
—
—
Restricted Cash
101.10
+111.31%
47.85
+9.62%
43.65
-23.02%
56.70
Other Current Assets
3.67
-25.62%
4.93
-36.04%
7.71
+3.25%
7.47
Total Non Current Assets
1,294.65
-0.83%
1,305.47
+0.47%
1,299.31
-2.23%
1,328.95
Net PPE
144.48
+4.47%
138.30
+3.53%
133.59
+1.19%
132.01
Gross PPE
341.03
+11.19%
306.69
+12.33%
273.02
+5.55%
258.66
Accumulated Depreciation
-196.55
-16.72%
-168.39
-20.77%
-139.43
-10.10%
-126.64
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
170.56
+12.88%
151.10
+23.34%
122.50
+50.35%
81.48
Construction In Progress
23.43
+86.83%
12.54
+7.96%
11.61
-58.85%
28.22
Other Properties
128.44
+2.47%
125.33
+3.60%
120.98
-6.53%
129.44
Leases
18.61
+4.99%
17.72
-1.10%
17.92
-8.15%
19.51
Goodwill And Other Intangible Assets
962.25
-1.95%
981.43
-3.18%
1,013.64
-4.19%
1,057.94
Goodwill
737.95
+0.44%
734.73
-0.15%
735.81
+0.21%
734.27
Other Intangible Assets
224.30
-9.08%
246.70
-11.20%
277.83
-14.16%
323.67
Investments And Advances
60.74
+15.16%
52.74
+22.79%
42.95
+30.46%
32.92
Other Investments
60.74
+15.16%
52.74
+22.79%
42.95
+30.46%
32.92
Non Current Accounts Receivable
3.52
-55.28%
7.87
-33.56%
11.85
-19.63%
14.74
Non Current Deferred Assets
60.50
+0.15%
60.41
+64.97%
36.62
+50.16%
24.39
Non Current Deferred Taxes Assets
58.34
+1.51%
57.47
+74.67%
32.90
+47.35%
22.33
Non Current Prepaid Assets
52.84
-3.32%
54.66
+4.28%
52.41
-11.88%
59.48
Other Non Current Assets
10.32
+2.63%
10.06
+22.07%
8.24
+10.52%
7.46
Total Liabilities Net Minority Interest
742.91
-15.35%
877.65
-15.44%
1,037.92
-3.95%
1,080.62
Current Liabilities
476.61
-19.99%
595.68
+61.96%
367.79
-14.16%
428.45
Payables And Accrued Expenses
124.00
-16.42%
148.37
+14.49%
129.59
-17.47%
157.02
Payables
48.01
-24.07%
63.23
+33.90%
47.22
-35.34%
73.03
Accounts Payable
43.99
-15.05%
51.78
+15.00%
45.03
-28.97%
63.39
Current Accrued Expenses
76.00
-10.74%
85.14
+3.37%
82.37
-1.94%
83.99
Pensionand Other Post Retirement Benefit Plans Current
57.17
-5.20%
60.31
+16.53%
51.75
-29.54%
73.45
Total Tax Payable
4.02
-64.90%
11.44
+422.27%
2.19
-77.28%
9.64
Current Debt And Capital Lease Obligation
11.96
-93.54%
185.03
+1659.14%
10.52
-2.26%
10.76
Current Debt
—
174.32
—
—
Other Current Borrowings
—
174.32
—
—
Current Capital Lease Obligation
11.96
+11.71%
10.70
+1.75%
10.52
-2.26%
10.76
Current Deferred Liabilities
283.48
+40.35%
201.98
+14.80%
175.93
-6.02%
187.21
Current Deferred Revenue
283.48
+40.35%
201.98
+14.80%
175.93
-6.02%
187.21
Total Non Current Liabilities Net Minority Interest
266.30
-5.56%
281.97
-57.92%
670.13
+2.75%
652.17
Long Term Debt And Capital Lease Obligation
192.39
-2.60%
197.52
-67.27%
603.57
-0.40%
605.98
Long Term Debt
167.60
+0.72%
166.40
-70.79%
569.66
+0.55%
566.57
Long Term Capital Lease Obligation
24.79
-20.34%
31.12
-8.22%
33.91
-13.94%
39.41
Non Current Deferred Liabilities
63.94
-17.21%
77.23
+28.20%
60.24
+52.59%
39.48
Non Current Deferred Revenue
63.25
-16.91%
76.12
+29.85%
58.62
+56.81%
37.38
Non Current Deferred Taxes Liabilities
0.68
-38.36%
1.11
-31.60%
1.62
-22.67%
2.10
Other Non Current Liabilities
9.97
+38.13%
7.22
+14.25%
6.32
-5.97%
6.72
Stockholders Equity
1,231.81
-0.92%
1,243.31
+4.57%
1,188.95
+5.20%
1,130.14
Common Stock Equity
1,231.81
-0.92%
1,243.31
+4.57%
1,188.95
+5.20%
1,130.14
Capital Stock
0.06
+1.75%
0.06
+1.79%
0.06
+1.82%
0.06
Common Stock
0.06
+1.75%
0.06
+1.79%
0.06
+1.82%
0.06
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
57.83
+2.06%
56.66
+1.51%
55.82
+1.44%
55.03
Ordinary Shares Number
45.03
-2.92%
46.38
+1.85%
45.54
+1.77%
44.75
Treasury Shares Number
12.81
+24.54%
10.28
+0.00%
10.28
+0.00%
10.28
Additional Paid In Capital
1,223.98
+4.80%
1,167.88
+4.06%
1,122.29
+7.22%
1,046.76
Retained Earnings
384.94
+0.54%
382.89
+3.38%
370.36
-5.21%
390.73
Gains Losses Not Affecting Retained Earnings
-8.85
+48.51%
-17.20
-28.02%
-13.43
+21.39%
-17.09
Treasury Stock
368.31
+26.86%
290.32
+0.00%
290.32
+0.00%
290.32
Other Equity Adjustments
-8.85
+48.51%
-17.20
-28.02%
-13.43
+21.39%
-17.09
Total Equity Gross Minority Interest
1,231.81
-0.92%
1,243.31
+4.57%
1,188.95
+5.20%
1,130.14
Total Capitalization
1,399.41
-0.73%
1,409.71
-19.84%
1,758.62
+3.65%
1,696.71
Working Capital
203.46
-7.44%
219.81
-60.73%
559.78
+23.47%
453.37
Total Debt
204.34
-46.58%
382.55
-37.71%
614.09
-0.43%
616.74
Net Debt
—
—
101.69
-56.95%
236.21
Capital Lease Obligations
36.75
-12.14%
41.83
-5.86%
44.43
-11.44%
50.17
Net Tangible Assets
269.57
+2.93%
261.88
+49.38%
175.31
+142.82%
72.20
Tangible Book Value
269.57
+2.93%
261.88
+49.38%
175.31
+142.82%
72.20
Foreign Currency Translation Adjustments
—
—
—
-17.09
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
127.30
-32.19%
187.72
+3.66%
181.09
+132.83%
77.78
Cash Flow From Continuing Operating Activities
127.30
-32.19%
187.72
+3.66%
181.09
+132.83%
77.78
Net Income From Continuing Operations
2.05
-83.62%
12.53
+161.51%
-20.37
-460.68%
5.65
Depreciation Amortization Depletion
86.63
-3.48%
89.75
-6.07%
95.56
-3.64%
99.17
Depreciation
86.63
-3.48%
89.75
-6.07%
95.56
-3.64%
99.17
Depreciation And Amortization
86.63
-3.48%
89.75
-6.07%
95.56
-3.64%
99.17
Other Non Cash Items
2.65
-30.02%
3.79
-13.85%
4.40
+5.60%
4.16
Stock Based Compensation
44.50
+13.19%
39.32
-28.90%
55.30
-18.97%
68.25
Asset Impairment Charge
0.60
-88.89%
5.39
-51.03%
11.01
+3.33%
10.66
Deferred Tax
-1.29
+91.30%
-14.86
-34.47%
-11.05
+70.40%
-37.32
Deferred Income Tax
-1.29
+91.30%
-14.86
-34.47%
-11.05
+70.40%
-37.32
Operating Gains Losses
0.49
+107.46%
-6.54
-354.24%
2.57
+279.35%
0.68
Gain Loss On Sale Of PPE
0.49
-50.10%
0.98
-61.98%
2.57
+279.35%
0.68
Change In Working Capital
-8.33
-114.29%
58.33
+33.57%
43.67
+159.45%
-73.47
Change In Receivables
41.42
+928.15%
-5.00
-110.18%
49.15
+181.43%
-60.36
Change In Inventory
-11.22
-171.80%
15.63
-58.88%
38.02
+226.24%
-30.11
Change In Prepaid Assets
-5.95
-168.30%
-2.22
-126.99%
8.22
+2389.14%
-0.36
Change In Payables And Accrued Expense
-32.25
-208.56%
29.70
+160.22%
-49.33
-534.88%
11.34
Change In Accrued Expense
-22.97
-202.09%
22.50
+170.73%
-31.80
-266.54%
19.10
Change In Payable
-9.28
-228.75%
7.21
+141.14%
-17.52
-126.01%
-7.75
Change In Account Payable
-9.28
-228.75%
7.21
+141.14%
-17.52
-126.01%
-7.75
Change In Other Working Capital
16.38
-43.43%
28.95
+20.34%
24.06
-1.68%
24.47
Change In Other Current Assets
-6.86
-723.45%
1.10
+107.27%
-15.12
-281.17%
-3.97
Change In Other Current Liabilities
-9.85
-0.16%
-9.84
+13.09%
-11.32
+21.83%
-14.48
Investing Cash Flow
-60.36
-14.34%
-52.79
+4.04%
-55.02
+6.23%
-58.67
Cash Flow From Continuing Investing Activities
-60.36
-14.34%
-52.79
+4.04%
-55.02
+6.23%
-58.67
Net PPE Purchase And Sale
-40.41
-10.84%
-36.46
+12.08%
-41.47
+12.75%
-47.54
Purchase Of PPE
-40.41
-10.84%
-36.46
+12.08%
-41.47
+12.75%
-47.54
Capital Expenditure
-57.93
-9.74%
-52.79
+4.04%
-55.02
+9.42%
-60.74
Net Business Purchase And Sale
—
0.00
0.00
-100.00%
2.07
Purchase Of Business
—
0.00
0.00
+100.00%
-3.39
Net Intangibles Purchase And Sale
-17.52
-7.27%
-16.33
-20.59%
-13.54
-2.56%
-13.20
Purchase Of Intangibles
-17.52
-7.27%
-16.33
-20.59%
-13.54
-2.56%
-13.20
Net Other Investing Changes
-2.43
—
—
—
Financing Cash Flow
-218.32
+7.33%
-235.58
-1105.88%
23.42
+211.77%
-20.95
Cash Flow From Continuing Financing Activities
-218.32
+7.33%
-235.58
-1105.88%
23.42
+211.77%
-20.95
Net Issuance Payments Of Debt
-175.00
+22.38%
-225.46
0.00
0.00
Issuance Of Debt
0.00
-100.00%
166.27
0.00
0.00
Repayment Of Debt
-175.00
+55.33%
-391.73
0.00
0.00
Long Term Debt Issuance
0.00
-100.00%
166.27
0.00
0.00
Long Term Debt Payments
-175.00
+55.33%
-391.73
0.00
0.00
Net Long Term Debt Issuance
-175.00
+22.38%
-225.46
0.00
0.00
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
-77.60
0.00
0.00
+100.00%
-52.21
Common Stock Payments
-77.60
0.00
0.00
+100.00%
-52.21
Repurchase Of Capital Stock
-77.60
0.00
0.00
+100.00%
-52.21
Proceeds From Stock Option Exercised
16.87
-56.28%
38.58
+66.17%
23.22
-42.22%
40.18
Net Other Financing Charges
17.41
+135.76%
-48.70
-23973.53%
0.20
+102.29%
-8.93
Changes In Cash
-151.38
-50.40%
-100.65
-167.32%
149.50
+8220.48%
-1.84
Effect Of Exchange Rate Changes
3.80
+321.33%
-1.72
-26.74%
-1.35
-43.43%
-0.94
Beginning Cash Position
398.61
-20.43%
500.98
+41.99%
352.83
-0.78%
355.62
End Cash Position
251.03
-37.02%
398.61
-20.43%
500.98
+41.99%
352.83
Free Cash Flow
69.37
-48.59%
134.93
+7.02%
126.08
+639.85%
17.04
Interest Paid Supplemental Data
2.20
+35.53%
1.62
+12.93%
1.44
+0.00%
1.44
Income Tax Paid Supplemental Data
—
11.28
-44.19%
20.21
+6.34%
19.00
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
Sale Of Business
—
0.00
0.00
-100.00%
5.46
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category